Showing results (611-620 of 1,340) with videos related to

Sort By:
Pageof 134
Neuro-Oncology Advances|March 30, 2026
Characterization of patient-derived site-specific in vivo models of pediatric-type diffuse high-grade glioma using magnetic resonance imagingJessica K R Boult, Diana M Carvalho, Ketty Kessler, et al.
Neuro-Oncology Advances|May 4, 2026
Patient preferences for incidental findings in a genomic trial: Insights from the Copenhagen glioblastoma cohortAnders Overby Sjøstrøm, Maria Camilla Mathiasen, Ulrik Lassen, et al.
Neuro-Oncology Advances|April 30, 2026
TRK inhibitors in pediatric gliomasSébastien Perreault, François Doz
Neuro-Oncology Advances|April 15, 2026
Nutrition optimization in enhanced recovery after brain tumor surgery: scoping review of evidence, gaps, and a proposed perioperative nutrition scoreCamilla Regalia, Tirone Young, Zerubabbel K Asfaw, et al.
Neuro-Oncology Advances|April 30, 2026
"It was complete chaos day and night and no one was able to help": A qualitative study on the support needs of family members exposed to violence by patients with brain tumorsAmina Guenna Holmgren, Annika Malmström, Eskil Degsell, et al.
Neuro-Oncology Advances|April 30, 2026
Genetic landscape and molecular targets in pediatric pineal tumorsElena Pasquinelli, Milena Guidi, Iacopo Sardi
Neuro-Oncology Advances|April 6, 2026
Genome-wide profiling of lncRNAs in pediatric intracranial ependymomas identifies H19 as a novel pathogenic driverStine M Vissing, Ulvi Ahmadov, Timothy A Ritzmann, et al.
Neuro-Oncology Advances|April 6, 2026
Intelligent histology for tumor neurosurgeryXinhai Hou, Akhil V Kondepudi, Cheng Jiang, et al.
Neuro-Oncology Advances|March 19, 2026
The TNFR superfamily member Fn14 impacts immunity and survival in experimental gliomas and response to immune checkpoint inhibitor therapy in glioblastoma patientsPranjali P Kanvinde, Adarsha P Malla, Alexandra A Seas, et al.
Neuro-Oncology Advances|April 21, 2026
Beyond cell cycle control: CDKN2A loss is associated with altered NAD+ metabolic states and increased sensitivity to NAMPT inhibition in glioblastomaSwati Dubey, Guanqiao Yu, Ryana Aboul-Hosn, et al.
Pageof 134